Amelioration of age-related brain function decline by Bruton's tyrosine kinase inhibition.
Ontology highlight
ABSTRACT: One of the hallmarks of aging is the progressive accumulation of senescent cells in organisms, which has been proposed to be a contributing factor to age-dependent organ dysfunction. We recently reported that Bruton's tyrosine kinase (BTK) is an upstream component of the p53 responses to DNA damage. BTK binds to and phosphorylates p53 and MDM2, which results in increased p53 activity. Consistent with this, blocking BTK impairs p53-induced senescence. This suggests that sustained BTK inhibition could have an effect on organismal aging by reducing the presence of senescent cells in tissues. Here, we show that ibrutinib, a clinically approved covalent inhibitor of BTK, prolonged the maximum lifespan of a Zmpste24-/- progeroid mice, which also showed a reduction in general age-relat
SUBMITTER: Ekpenyong-Akiba AE
PROVIDER: S-EPMC6974713 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA